Literature DB >> 29802989

An integrated strategy to improve data acquisition and metabolite identification by time-staggered ion lists in UHPLC/Q-TOF MS-based metabolomics.

Yang Wang1, Ruibing Feng1, Chengwei He1, Huanxing Su1, Huan Ma2, Jian-Bo Wan3.   

Abstract

The narrow linear range and the limited scan time of the given ion make the quantification of the features challenging in liquid chromatography-mass spectrometry (LC-MS)-based untargeted metabolomics with the full-scan mode. And metabolite identification is another bottleneck of untargeted analysis owing to the difficulty of acquiring MS/MS information of most metabolites detected. In this study, an integrated workflow was proposed using the newly established multiple ion monitoring mode with time-staggered ion lists (tsMIM) and target-directed data-dependent acquisition with time-staggered ion lists (tsDDA) to improve data acquisition and metabolite identification in UHPLC/Q-TOF MS-based untargeted metabolomics. Compared to the conventional untargeted metabolomics, the proprosed workflow exhibited the better repeatability before and after data normalization. After selecting features with the significant change by statistical analysis, MS/MS information of all these features can be obtained by tsDDA analysis to facilitate metabolite identification. Using time-staggered ion lists, the workflow is more sensitive in data acquisition, especially for the low-abundant features. Moreover, the metabolites with low abundance tend to be wrongly integrated and triggered by full scan-based untargeted analysis with MSE acquisition mode, which can be greatly improved by the proposed workflow. The integrated workflow was also successfully applied to discover serum biosignatures for the genetic modification of fat-1 in mice, which indicated its practicability and great potential in future metabolomics studies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabolomics; Time-staggered ion list; tsDDA; tsMIM

Mesh:

Substances:

Year:  2018        PMID: 29802989     DOI: 10.1016/j.jpba.2018.05.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography-mass spectrometry.

Authors:  Fujian Zheng; Xinjie Zhao; Zhongda Zeng; Lichao Wang; Wangjie Lv; Qingqing Wang; Guowang Xu
Journal:  Nat Protoc       Date:  2020-06-24       Impact factor: 13.491

2.  An integrated strategy for comprehensive characterization of metabolites and metabolic profiles of bufadienolides from Venenum Bufonis in rats.

Authors:  Wen-Long Wei; Hao-Jv Li; Wen-Zhi Yang; Hua Qu; Zhen-Wei Li; Chang-Liang Yao; Jin-Jun Hou; Wan-Ying Wu; De-An Guo
Journal:  J Pharm Anal       Date:  2021-02-12

3.  A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

Authors:  Qingxia Yang; Jiajun Hong; Yi Li; Weiwei Xue; Song Li; Hui Yang; Feng Zhu
Journal:  Brief Bioinform       Date:  2020-12-01       Impact factor: 11.622

4.  Comparing Targeted vs. Untargeted MS2 Data-Dependent Acquisition for Peak Annotation in LC-MS Metabolomics.

Authors:  Isabel Ten-Doménech; Teresa Martínez-Sena; Marta Moreno-Torres; Juan Daniel Sanjuan-Herráez; José V Castell; Anna Parra-Llorca; Máximo Vento; Guillermo Quintás; Julia Kuligowski
Journal:  Metabolites       Date:  2020-03-26

Review 5.  Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches.

Authors:  Li Chen; Fanyi Zhong; Jiangjiang Zhu
Journal:  Metabolites       Date:  2020-08-27

Review 6.  Recent advances in analytical strategies for mass spectrometry-based lipidomics.

Authors:  Tianrun Xu; Chunxiu Hu; Qiuhui Xuan; Guowang Xu
Journal:  Anal Chim Acta       Date:  2020-09-30       Impact factor: 6.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.